awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47942762-38697092-44A3-4A8B-A1BF-080E738B02AE
Q47942762-38697092-44A3-4A8B-A1BF-080E738B02AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47942762-38697092-44A3-4A8B-A1BF-080E738B02AE
Future Clinical Trials: Genetically Driven Trials.
P2860
Q47942762-38697092-44A3-4A8B-A1BF-080E738B02AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47942762-38697092-44A3-4A8B-A1BF-080E738B02AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e13b6ad05ee07ea14a97e1115da1a7f57856bf40
P2860
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.